5 completed, 2 suspended, 1 unknown, 1 withdrawn. 9 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 5, Suspended 2, Unknown 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Suspended 1 |
Follow Placebo Oil: new trials by email Literature Review of Placebo Oil trials Research Report on Placebo Oil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of CBD-Rich Oil on Aversive Memory Reconsolidation Interoceptive Aversive Memory Reactivation, Cannabidiol (CBD)-Rich Broad Spectrum Hemp Extract Oil, Placebo Oil - Anxiety and Fear | Phase 1 / Phase 2 | Unknown | University of Texas at Austin | 96 | 2022-01-01 | 2022-01-19 |
| CBD Oil for Reducing Emotional Impact of COVID-19 CBD Isolate, Full Spectrum CBD Oil, Broad-Spectrum CBD Oil - Anxiety Depression, Alcohol Abuse | Phase 2 / Phase 3 | Suspended | University of Texas at Austin | 200 | 2020-12-04 | 2023-11-22 |
| CHI-902 for Treatment of Social Anxiety Disorder CHI-902, Placebo - Social Anxiety Disorder | Phase 2 | Withdrawn | Canopy Growth Corporation | 2020-01-24 | 2020-06-04 | |
| Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder CBD Isolate, CBD Broad Spectrum, Placebo oil - Post Traumatic Stress Disorder | Phase 2 | Suspended | University of Texas at Austin | 150 | 2020-01-15 | 2023-11-22 |
| The Effect of Triheptanoin on Fatty Acid Oxidation and Exercise Tolerance in Patients With Glycogenoses Triheptanoin, Placebo Oil - Tarui Disease, Debrancher Deficiency | Phase 2 | Completed | Copenhagen University Hospital, Rigshospitalet | 3 | 2018-08-15 | 2024-02-22 |
| The Effect of Cannabis on Dementia Related Agitation and Aggression Cannabis, Placebo oil - Agitation Related to Dementia | Phase 2 | Completed | TO Pharmaceuticals | 64 | 2017-12-07 | 2022-03-08 |
| Triheptanoin in Mc Ardle Triheptanoin, Placebo oil - Glycogen Storage Disease Type V | Phase 2 | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 12 | 2016-11-16 | 2025-09-04 |
| The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V) Triheptanoin, Placebo oil - Glycogen Storage Disease Type V | Phase 2 | Completed | Copenhagen University Hospital, Rigshospitalet | 22 | 2015-04-01 | 2019-10-16 |
| Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome 5000IU vitamin D, 10000IU vitamin D, Placebo - Clinically Isolated Syndrome, Multiple Sclerosis | Phase 1 / Phase 2 | Completed | University College Dublin | 64 | 2012-11-06 | 2017-05-03 |
Anxiety Disorders (2) · Glycogen Storage Disease Type V (2) · Alcoholism (1) · COVID-19 (1) · Color Vision Defects (1) · Fractures, Stress (1) · Glycogen Storage Disease (1) · Glycogen Storage Disease Type III (1) · Glycogen Storage Disease Type VII (1) · Marijuana Abuse (1) · Multiple Sclerosis (1) · Parasomnias (1) · Phobia, Social (1) · Stress Disorders, Post-Traumatic (1) · Substance-Related Disorders (1)
University of Texas at Austin (3) · Copenhagen University Hospital, Rigshospitalet (2) · Canopy Growth Corporation (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · TO Pharmaceuticals (1) · University College Dublin (1)
United States (3) · Denmark (2) · Canada (1) · France (1) · Ireland (1) · Israel (1)
Michael J Telch, Ph.D. (2) · Karen L Madsen, MD (1) · Mark Ware, MD (1) · Michael Hutchinson, MB, FRCP (1) · Michael J. Telch, PhD (1) · Vered Hermush, Dr (1)
PMID 12122118, PMID 12210323, PMID 1281472, PMID 15293280, PMID 15781190, PMID 1580445, PMID 16602102, PMID 16763895, PMID 16763896, PMID 17584774, PMID 1824792, PMID 18401027, PMID 18541798, PMID 18645163, PMID 18929906, PMID 19237700, PMID 20357282, PMID 20393176, PMID 20631546, PMID 20655781, PMID 2199596, PMID 2295969, PMID 23031366, PMID 23507172, PMID 23981773, PMID 24453079, PMID 25272951, PMID 25832663, PMID 26255073, PMID 26652229, PMID 28932990, PMID 31520525, PMID 33660625, PMID 3447177, PMID 34532852, PMID 35811050, PMID 36148467, PMID 36154908, PMID 5235982, PMID 7634753, PMID 8755644
2014 (1), 2017 (1)